Patients with fragile X syndrome present a variable phenotype, which contributes to the underdiagnosing of this condition. The use of clinical checklists in individuals with intellectual disability can help in selecting patients to be given priority in the molecular investigation of the fragile X mutation in the FMR1 gene. Some features included in checklists are better predictors than others, but they can vary among different populations and with patient age. In the present study, we evaluated 20 features listed in four clinical checklists from the literature, using a sample of 192 Brazilian male patients presenting with intellectual disability (30 positive and 162 negative for fragile X mutation). After statistical analysis, 12 out of the 20 items analyzed showed significant differences in their distributions between the two groups. These features were grouped in a new checklist that can help clinicians in their referral for fragile X testing in patients with developmental delay.
Arvio, M., Peippo, M. & Simola, K.O. ( 1997) ‘Applicability of a Checklist for Clinical Screening of the Fragile X Syndrome’, Clinical Genetics52: 211-15.
2.
Butler, M.G., Mangrum, T., Gupta, R. & Singh, D.N. ( 1991) ‘A 15-Item Checklist for Screening Mentally Retarded Males for the Fragile X Syndrome’, Clinical Genetics39: 347-54.
3.
Christofolini, D.M., Lipay, M. V. N, Ramos, M.A.P., Brunoni, D. & Melaragno, M.I. ( 2007) ‘Clinical Checklists in the Selection of Mentally Retarded Males for Molecular Screening of Fragile X Syndrome’ , Genetics & Molecular Biology30: 1047-50.
4.
De Vries, B.B., Mohkamsing, S., van den Ouweland, A.M., Mol, E., Gelsema, K., van Rijn, M., Tibben, A., Halley, D.J., Duivenvoorden, H.J. , Oostra, B.A. & Niermeijer , M.F. (1999) ‘Screening for the Fragile X Syndrome among the Mentally Retarded: A Clinical Study. The Collaborative Fragile X Study Group’, Journal of Medical Genetics36: 467-70.
5.
De Vries, B.B., van den Ouweland, A.M., Mohkamsing, S., Duivenvoorden, H.J., Mol, E., Gelsema, K., van Rijn, M., Halley, D.J., Sandkuijl, L.A., Oostra, B.A., Tibben, A. & Niermeijer, M.F. ( 1997) ‘Screening and Diagnosis for the Fragile X Syndrome among the Mentally Retarded: An Epidemiological and Psychological Survey. Collaborative Fragile X Study Group’, American Journal of Human Genetics61: 660-7.
6.
Faria, A.P.M. ( 2006) ‘Investigação diagnóstica do retardo mental: diretrizes, normas e condutas’. www.fcm.unicamp.br/diretrizes/site_diretrizes_normas_condutas_fcm/invest_diag_ret_ment/invest_diag_ret_ment_pg1.html .
7.
Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick, R.G. Jr, Warren, S.T., et al. (1991) ‘Variation of the CGG Repeat at the Fragile X Site Results in Genetic Instability: Resolution of the Sherman Paradox’ , Cell67: 1047-58.
8.
Giangreco, C.A., Steele, M.W., Aston, C.E., Cummins, J.H. & Wenger, S.L. ( 1996) ‘A Simplified Six-Item Checklist for Screening for Fragile X Syndrome in the Pediatric Population’, Journal of Paediatrics129: 611-14.
9.
Haddad, L.A., Mingroni-Netto, R.C., Vianna-Morgante, A.M. & Pena, S.D. ( 1996) ‘A PCR-Based Test Suitable for Screening for Fragile X Syndrome among Mentally Retarded Males’, Human Genetics97: 808-12.
10.
Hagerman, R.J. ( 1987) ‘Fragile X syndrome’, Current Problems in Paediatrics17: 621-74.
11.
Hagerman, R.J., Amiri, K., & Cronister, A. ( 1991) ‘Fragile X Checklist’, American Journal of Medical Genetics38: 283-7.
12.
Hagerman, R.J., Staley, L.W., O’Conner, R., Lugenbeel, K., Nelson, D., McLean, S.D. & Taylor, A. ( 1996) ‘Learning-Disabled Males with a Fragile X CGG Expansion in the Upper Premutation Size Range’, Pediatrics97: 122-6.
13.
Hjalgrim, H., Gronskov, K. & Brondum-Nielsen, K. ( 1998) ‘Fragile X Syndrome: Diagnosis, Genetics and Clinical Findings (in Danish)’, Ugeskr Laeger160: 5330-4.
14.
Johnson, V.A. ( 2008) ‘Checklist Assessments of FMR1 Gene Mutation Phenotypes’ , Journal of Cultural Diversity15 (3): 117-31.
15.
Kirkilionis, A.J., Pozsonyi, J. & Sergovich, F.R. ( 1988) ‘The Use of Testicular Volume as a Clinical Marker for Cytogenetic Disorders in Mentally Retarded Males’, Journal of Mental Deficiency Research32 (Pt 1): 19-30.
16.
Lachiewicz, A.M., Dawson, D.V. & Spiridigliozzi, G.A. ( 2000) ‘Physical Characteristics of Young Boys with Fragile X Syndrome: Reasons for Difficulties in Making a Diagnosis in Young Males’ , American Journal of Medical Genetics92: 229-36.
17.
Laing, S., Partington, M., Robinson, H. & Turner, G. ( 1991) ‘Clinical Screening Score for the Fragile X (Martin-Bell) Syndrome’, American Journal of Medical Genetics38: 256-9.
18.
Limprasert, P., Ruangdaraganon, N., Vasiknanonte, P., Sura, T., Jaruratanasirikul, S., Sriwongpanich, N. & Sriplung, H. ( 2000) ‘A Clinical Checklist for Fragile X Syndrome: Screening of Thai Boys with Developmental Delay of Unknown Cause’, Journal of the Medical Association of Thailand83: 1260-6.
19.
Maes, B., Fryns, J.P., Ghesquiere, P. & Borghgraef, M. ( 2000) ‘Phenotypic Checklist to Screen for Fragile X Syndrome in People with Mental Retardation’, Mental Retardation38: 207-15.
20.
Mandel, J.L. & Biancalana, V. ( 2004) ‘Fragile X Mental Retardation Syndrome: From Pathogenesis to Diagnostic Issues’, Growth Hormone & IGF Research14 Suppl. A: S158-65.
21.
Mingroni-Netto, R.C., Haddad, L.A. & Vianna-Morgante, A.M. ( 1996) ‘The Number of CGG Repeats of the FMR1 Locus in Premutated and Fully Mutated Heterozygotes and their Offspring: Implications for the Origin of Mosaicism’, American Journal of Medical Genetics64: 270-3.
22.
Oostra, B.A. & Willemsen, R. ( 2009) ‘FMR1: A Gene with Three Faces’, Biochim Biophys Acta (e-publication ahead of print).
23.
Thake, A., Todd, J., Bundey, S. & Webb, T. ( 1985) ‘Is It Possible to Make a Clinical Diagnosis of the Fragile X Syndrome in a Boy?’, Archives of Disease in Childhood60: 1001-7.
